BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23999183)

  • 21. Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease.
    Lin J; Lin L; Chen S; Yu L; Chen S; Xia Z
    J Vet Diagn Invest; 2021 Mar; 33(2):288-293. PubMed ID: 33543676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of glomerular filtration rate in cats: methods and advantages over routine markers of renal function.
    Finch N
    J Feline Med Surg; 2014 Sep; 16(9):736-48. PubMed ID: 25146661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective case-control study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease.
    Gowan RA; Lingard AE; Johnston L; Stansen W; Brown SA; Malik R
    J Feline Med Surg; 2011 Oct; 13(10):752-61. PubMed ID: 21906984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary F
    Whitehouse W; Quimby J; Wan S; Monaghan K; Robbins R; Trepanier LA
    J Vet Intern Med; 2017 Mar; 31(2):449-456. PubMed ID: 28160524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation for association between urolithiasis and chronic kidney disease in cats.
    Cléroux A; Alexander K; Beauchamp G; Dunn M
    J Am Vet Med Assoc; 2017 Apr; 250(7):770-774. PubMed ID: 28306489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symmetric Dimethylarginine: Improving the Diagnosis and Staging of Chronic Kidney Disease in Small Animals.
    Relford R; Robertson J; Clements C
    Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):941-60. PubMed ID: 27499007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital portosystemic shunts in cats: investigation, diagnosis and stabilisation.
    Tivers M; Lipscomb V
    J Feline Med Surg; 2011 Mar; 13(3):173-84. PubMed ID: 21338942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective evaluation of healthy Ragdoll cats for chronic kidney disease by routine laboratory parameters and ultrasonography.
    Paepe D; Bavegems V; Combes A; Saunders JH; Daminet S
    J Feline Med Surg; 2013 Oct; 15(10):849-57. PubMed ID: 23413268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of intravenous adipose-derived allogeneic mesenchymal stem cells for the treatment of feline chronic kidney disease: a randomized, placebo-controlled clinical trial in eight cats.
    Quimby JM; Webb TL; Randall E; Marolf A; Valdes-Martinez A; Dow SW
    J Feline Med Surg; 2016 Feb; 18(2):165-71. PubMed ID: 25784460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal biomarkers in cats: A review of the current status in chronic kidney disease.
    Kongtasai T; Paepe D; Meyer E; Mortier F; Marynissen S; Stammeleer L; Defauw P; Daminet S
    J Vet Intern Med; 2022 Mar; 36(2):379-396. PubMed ID: 35218249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symmetrical Dimethylarginine: Evaluating Chronic Kidney Disease in the Era of Multiple Kidney Biomarkers.
    Michael H; Szlosek D; Clements C; Mack R
    Vet Clin North Am Small Anim Pract; 2022 May; 52(3):609-629. PubMed ID: 35379500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated measurements of renal function in evaluating its decline in cats.
    Finch NC; Syme HM; Elliott J
    J Feline Med Surg; 2018 Dec; 20(12):1144-1148. PubMed ID: 29451445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of evaluation of kidney function and classification of chronic kidney disease (CKD)--including CKD clinical practice guide 2012].
    Horio M
    Rinsho Byori; 2013 Jul; 61(7):616-21. PubMed ID: 24205704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury.
    Lawson J; Elliott J; Wheeler-Jones C; Syme H; Jepson R
    Vet J; 2015 Jan; 203(1):18-26. PubMed ID: 25475166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Kidney Disease in Aged Cats: Clinical Features, Morphology, and Proposed Pathogeneses.
    Brown CA; Elliott J; Schmiedt CW; Brown SA
    Vet Pathol; 2016 Mar; 53(2):309-26. PubMed ID: 26869151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of urinary biomarkers for azotaemic chronic kidney disease in cats.
    Williams TL; Archer J
    J Small Anim Pract; 2016 Mar; 57(3):122-9. PubMed ID: 26699224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical management of feline chronic kidney disease in Portugal: a questionnaire-based study.
    Magalhães TR; Lourenço AL; Corbee RJ; Queiroga FL
    J Feline Med Surg; 2023 Nov; 25(11):1098612X231206125. PubMed ID: 37987623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease.
    Sparkes AH; Caney S; Chalhoub S; Elliott J; Finch N; Gajanayake I; Langston C; Lefebvre HP; White J; Quimby J
    J Feline Med Surg; 2016 Mar; 18(3):219-39. PubMed ID: 26936494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contrast-Enhanced Ultrasound Examination for the Assessment of Renal Perfusion in Cats with Chronic Kidney Disease.
    Stock E; Paepe D; Daminet S; Vandermeulen E; Duchateau L; Saunders JH; Vanderperren K
    J Vet Intern Med; 2018 Jan; 32(1):260-266. PubMed ID: 29171085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary liver-type fatty acid-binding protein in clinically healthy elderly cats: Evaluation of its potential to detect IRIS stage 1 chronic kidney disease and borderline proteinuria.
    Kongtasai T; Paepe D; Mortier F; Marynissen S; Meyer E; Duchateau L; Daminet S
    Vet Med Sci; 2023 Jan; 9(1):3-12. PubMed ID: 36418182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.